drugset / Trial / NCT00777868
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and effectiveness of two concentrations of IDP-108 in treating patients with onychomycosis
Timeline
- Start
- 2007-10
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efinaconazole | Small molecule | 5 % | Topical |
| Subject | Efinaconazole | Small molecule | 10 % | Topical |